Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Response Curve: Conventional Versus Nonmonotonic01:21

Dose Response Curve: Conventional Versus Nonmonotonic

The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–response curves, which include graded and quantal relationships, are key to this understanding. Graded dose–response curves depict the spectrum of a biological reaction to different doses within an individual, indicating that as the drug dosage increases, so does the intensity of the response. On the other hand, quantal dose–response relationships...
Pharmacodynamic Models: Linear Concentration–Effect Model01:15

Pharmacodynamic Models: Linear Concentration–Effect Model

The linear concentration–effect model, underpinned by the principle that pharmacological effect (E) is directly proportional to plasma drug concentration (C), emerges as a pivotal simplification of the Emax model for conditions where C is significantly less than EC50. This model portrays a linear trajectory of the concentration–effect relationship when drug levels are markedly below the EC50 threshold.Despite its inherent assumption of continuous effect augmentation with increasing drug...
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship01:23

Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship

Pharmacodynamics explores the relationship between drug concentration and its effect. In a quantal response drug, the duration of action better correlates with drug concentration, while for graded effect drugs, the intensity of response is more relevant. This intensity depends on the dose, drug removal rate, and the region of the concentration–response curve.The concentration–response curve can be divided into three regions. Region 3 (80–100% maximum response) demonstrates that even as drug...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-cancer effects of radiation exposure: Cataracts, diseases of the circulatory system, and beyond.

Annals of the ICRP·2026
Same author

Machine learning techniques for the prediction of indoor gamma-ray dose rates - Strengths, weaknesses and implications for epidemiology.

Journal of environmental radioactivity·2024
Same author

Change in salt intake affects blood pressure of chimpanzees implications for human populations. Circulation 116: 1563-1568, 2007.

Clinical journal of the American Society of Nephrology : CJASN·2023
Same author

The Evidence for Excess Risk of Cancer and Non-Cancer Disease at Low Doses and Dose Rates.

Radiation research·2022
Same author

THYROID SCREENING AND RELIABILITY OF RADIATION THYROID DOSES FOR THE BELARUSIAN IN UTERO COHORT.

Problemy radiatsiinoi medytsyny ta radiobiolohii·2021
Same author

Modelling the bimodal distribution of indoor gamma-ray dose-rates in Great Britain.

Radiation and environmental biophysics·2018
Same journal

Monoallelic germline RAD51C, RAD51D, and BRIP1 variants in hereditary cancer testing: Variant spectrum and clinical counselling implications.

Mutation research·2026
Same journal

Prediction of hepatocellular carcinoma associated biomarkers in TP53 gene; A comprehensive in silico analysis.

Mutation research·2026
Same journal

IDH1 mutation promotes angiogenesis via upregulation of hypoxia inducible factor 1 alpha in glial tumors.

Mutation research·2026
Same journal

Targeting overexpressed oncogenes in esophageal cancer through miRNA-mediated gene silencing: Insights from binding affinity and thermodynamic profiling.

Mutation research·2026
Same journal

The active compound quercetin from Polygonum cuspidatum targets COL3A1 to enhance CD8⁺ T cell cytotoxicity in gastric cancer.

Mutation research·2026
Same journal

E2F1 promotes LIHC malignant phenotype via NEK2-mediated Wnt/β-catenin and Notch activation and EMT.

Mutation research·2026
See all related articles

Related Experiment Videos

Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?

M P Little1

  • 1Department of Epidemiology and Biostatistics, Imperial College School of Public Health, Faculty of Medicine, St Mary's Campus, Norfolk Place, London W2 1PG, UK.

Mutation Research
|January 29, 2010
PubMed
Summary
This summary is machine-generated.

Radiation exposure shows a linear dose-response for cancer risk and non-malignant diseases. Evidence does not support low-dose thresholds or hormesis, with non-DNA-targeted effects unlikely for cancer but possible for cardiovascular disease.

Related Experiment Videos

Area of Science:

  • Radiation Epidemiology
  • Toxicology
  • Public Health

Background:

  • Assessing radiation dose-response relationships is crucial for understanding health risks.
  • Previous studies suggest potential non-linear effects and non-targeted mechanisms.
  • Investigating both malignant and non-malignant diseases provides a comprehensive view of radiation impacts.

Purpose of the Study:

  • To review evidence for linearity in radiation dose-response for malignant and non-malignant diseases.
  • To evaluate potential mechanisms, including non-targeted effects.
  • To assess the role of low-dose radiation in cardiovascular disease.

Main Methods:

  • Review of epidemiological studies on Japanese atomic bomb survivors and other exposed groups.
  • Analysis of dose-response relationships for various cancers and non-malignant diseases.
  • Evaluation of biological mechanisms, including DNA-targeted and non-targeted effects.

Main Results:

  • Cancer risks generally show linearity with dose, with no strong evidence for thresholds or hormesis.
  • Non-malignant diseases, particularly cardiovascular disease, show less consistent dose-response patterns across studies.
  • Non-DNA-targeted effects are unlikely for cancer but may play a role in radiation-induced cardiovascular disease via inflammation.

Conclusions:

  • The dose-response for radiation-induced cancer is largely linear at low to moderate doses.
  • Evidence for non-linear effects or thresholds for cancer is not supported.
  • While radiation-associated cardiovascular disease is observed, its mechanisms and dose-response require further investigation, with a potential role for non-targeted effects.